MET and cancer: HGF/Met signaling can induce stromal cells to disrupt cell-cell junctions, expose extracellular matrix, and promote growth, adhesion, migration, invasion and vascular endothelial cell growth of various malignant tumor cells, including ovarian cancer [49].